Phlebolymphology N°101 – Editorial
In this new issue of Phlebolymphology you will find the articles as below:
The introduction and wide use of the CEAP classification for chronic venous disorders has made it possible to conduct large epidemiological studies and develop a set of clinical practice guidelines. Global use of this uniform classification has led to multiple comparable studies that have provided new evidence and improved understanding of chronic venous disease. Fedor LURIE (USA) reports the highlights from the 2020 update of the CEAP classification, which was realized by a task force of the American Venous Forum.
Air plethysmography (APG) and ambulatory venous pressure (AMVP) measurements, once popular, have gradually declined in use to near extinction. However, they can provide a more quantitative evaluation of reflux and disease severity than duplex ultrasound alone. Seshadri RAJU (USA) shares experience with these tests in 8456 CVD limbs seen over a 20-year period.
Iliofemoral venous obstruction is increasingly recognized as a major cause of post-thrombotic syndrome. Gerard O’SULLIVAN (Ireland) discusses the optimal method for imaging the
iliofemoral venous segment.
Vadim BOGACHEV (Russia) presents the results of a study, assessing the effectiveness of the micronized purified flavonoid fraction–based conservative treatment in patients with chronic venous edema as part of a prospective, observational program (VAP-C3; Vein Act Prolonged-C3) that evaluated the management of patients with chronic venous edema caused by the primary forms of CVD in real clinical practice.
Enjoy reading this issue!
Dr H. Pelin Yaltirik